by Oscar Jofre | May 23, 2022 | Capital Markets, Capital Raising, Regulation
In recent years, public perception of cannabis is gaining positive momentum. As of April 2021, 35 states have made medical marijuana legal, with 18 of them legalizing it recreationally. This growth has been tremendous, raising the industry’s value to over $13 billion...
by Oscar Jofre | May 13, 2022 | Capital Markets, Capital Raising, Regulation, SEC
“It’s About Time” Up until now, it was a real challenge for Cannabis companies to take advantage of Reg A+ exemptions that allow private companies to raise up to $75 million from the crowd; accredited and non-accredited investors alike. So you have the...
by Oscar Jofre | Mar 18, 2022 | Capital Raising, Regulation
Marking a huge step forward in equity crowdfunding opportunities for entrepreneurs and investors alike, one year ago, the SEC’s game-changing decision went into effect that allowed businesses to raise $75 million through RegA+ and $5 million from RegCF. These new...
by Oscar Jofre | Feb 7, 2022 | Capital Markets, Capital Raising, Regulation, SEC
It is essential to be familiar with the different regulations that govern how companies can raise capital in today’s business world. One important rule is Regulation S. This article will give you a basic overview of Regulation S, how it affects businesses, and...
by Oscar Jofre | Jan 28, 2022 | Regulation, SEC, Secondary Markets
Regulation A+ (RegA+) was passed into law by the SEC in the JOBS Act, making it possible for companies to raise funding from the general public and not just from accredited investors. Since March 2021, companies have been able to take advantage of the limit’s...
by Oscar Jofre | Jan 26, 2022 | Capital Markets, Capital Raising, KoreConX, KorePartner, News Releases, Regulation
Medtech and Life Sciences main event will be held next March in California. KoreConX is one of the supporting sponsors. NEW YORK, January 26, 2022 – KoreConX is pleased to announce its partnership with LSI Emerging Medtech Summit 2022, which will be held March...
